A solid pharmaceutical dosage formulation

Details for Australian Patent Application No. 2006216856 (hide)

Owner Abbott Laboratories

Inventors Berndl, Gunther; Breitenbach, Jorg; Rosenberg, Joerg; Ghosh, Soumojeet; Alani, Laman; Liepold, Bernd; Reinhold, Ulrich

Agent Spruson & Ferguson

Pub. Number AU-B-2006216856

PCT Pub. Number WO2006/091529

Priority 11/064,467 23.02.05 US

Filing date 21 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 8 March 2012

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/426 (2006.01) - 1,3-Thiazoles

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091529 Priority application(s): WO2006/091529

8 March 2012 Application Accepted

  Published as AU-B-2006216856

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216860-Shipping package

2006216855-System and method for three-phase data encryption